- received any investigational drug, rdv, or other antiviral treatment for covid-19 - alanine aminotransferase (alt) or aspartate aminotransferase (ast) > 5 times the upper limit of normal - invasive mechanical ventilation, noninvasive mechanical ventilation, ecmo, or rrt for acute kidney injury (aki) - positive serum pregnancy test at screening for women of childbearing potential or currently breastfeeding - known hypersensitivity to the study drug, metabolites, or formulation sulfobutylether-beta-cyclodextrin (sbecd) note: other protocol defined inclusion/exclusion criteria may apply

- received any investigational drug, rdv, or other antiviral treatment for covid-19 - alanine aminotransferase (alt) or aspartate aminotransferase (ast) > 5 times the upper limit of normal - invasive mechanical ventilation, noninvasive mechanical ventilation, ecmo, or rrt for acute kidney injury (aki) - positive serum pregnancy test at screening for women of childbearing potential or currently breastfeeding - known hypersensitivity to the study drug, metabolites, or formulation sulfobutylether-beta-cyclodextrin (sbecd) note: other protocol defined inclusion/exclusion criteria may apply